Drug Patents owned by Braintree Labs

1. Drug name - PIZENSY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10806743 BRAINTREE LABS Method of administering lactitol to reduce plasma concentration of lactitol May, 2037

(14 years from now)

Drugs and Companies using LACTITOL ingredient

Treatment: Method of treating chronic idiopathic constipation in adult patients.

Dosage: FOR SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
10GM FOR SOLUTION;ORAL Discontinued

2. Drug name - SUPREP BOWEL PREP KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6946149 BRAINTREE LABS Salt solution for colon cleansing Mar, 2023

(5 months from now)

Drugs and Companies using MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE ingredient

Treatment: Gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT SOLUTION;ORAL Prescription

3. Drug name - SUTAB

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11033498 BRAINTREE LABS Solid oral sulfate salt formulations for cleaning a colon and methods of using same Aug, 2037

(14 years from now)

US10143656 BRAINTREE LABS Solid oral sulfate salt formulations for cleaning a colon and methods of using same Aug, 2037

(14 years from now)

Drugs and Companies using MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE ingredient

Treatment: Gastrointestinal tablets indicated for cleansing the colon in preparation for colonoscopy

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.225GM;0.188GM;1.479GM TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.